QIAGEN Achieves ISO Certification for State-of-the-art Quality in Forensics

Tuesday, October 3, 2017 General News
Email Print This Page Comment bookmark
Font : A-A+

Assuring the highest accuracy in human identity testing for law enforcement and other uses

HILDEN, Germany and GERMANTOWN, Maryland, October 2, 2017

/PRNewswire/ --

QIAGEN (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced that its manufacturing and supply chain for consumables and other products for forensic and human identity testing has been certified by Bureau Veritas, a leading inspection agency, as meeting the latest international standards for products used in forensic testing. QIAGEN is a global leader in molecular testing solutions for human identification and has actively supported the development of global forensic standards. In pursuit of continuous improvement, QIAGEN has a long history of working with experts in forensic sciences and law enforcement to upgrade requirements designed to minimize the contamination of samples and to ensure the highest level of accuracy in DNA fingerprinting.

The Bureau Veritas certification represents a seal of approval that QIAGEN complies with the latest standard, known as ISO18385:2016, adopted to prevent contamination of products for DNA casework and reference databases. The requirements cover the manufacturing of products used in the collection, storage and analysis of human DNA during forensic testing, including sampling kits such as swabs, containers and packaging, and consumables used in the analysis of DNA samples by forensic laboratories.

Click here for the full press release

http://corporate.qiagen.com/newsroom/press-releases/2017/2017-10-02-HID-ISO-Certification?sc_lang=en

Contacts: QIAGEN Investor Relations           John Gilardi +49-2103-29-11711     e-mail: [email protected]                           Public Relations Dr. Thomas Theuringer +49-2103-29-11826 e-mail: [email protected]

SOURCE Qiagen N.V.



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Find a Doctor
Advertisement

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook